X, S., T, S., J, Y., & Z, Z. (2025). Combining Hepatic Arterial Interventional Therapies with Lenvatinib and Programmed Cell Death-1 Inhibitors for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Single-Center, Real-World Study. Dove Medical Press.
Chicago Style (17th ed.) CitationX, Shen, Shao T, Yu J, and Zhang Z. Combining Hepatic Arterial Interventional Therapies with Lenvatinib and Programmed Cell Death-1 Inhibitors for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Single-Center, Real-World Study. Dove Medical Press, 2025.
MLA (9th ed.) CitationX, Shen, et al. Combining Hepatic Arterial Interventional Therapies with Lenvatinib and Programmed Cell Death-1 Inhibitors for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Single-Center, Real-World Study. Dove Medical Press, 2025.